Navigation Links
Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement
Date:5/27/2009

NORCROSS, Ga., May 27 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a five-year agreement with Alverno Clinical Laboratories, LLC, one of the largest regional hospital laboratory integrated delivery systems in the nation, serving 27 hospitals in Illinois and Indiana.

Under the agreement, Alverno is standardizing pre-transfusion testing in 26 facilities with Immucor automation through the acquisition of 24 Echo instruments and 2 Capture Workstations. Additionally, Immucor will be the primary source for Alverno's blood bank reagent needs.

"We are pleased to partner with such an innovative organization as Alverno," stated Dr. Gioacchino De Chirico, President and Chief Executive Officer of Immucor. "We believe that integrated delivery networks can achieve significant benefits both in terms of improving operational efficiency and improving patient safety through standardizing their blood bank operations with Immucor automation."

"Our goal is to produce accurate and timely test results while implementing standardized best practices across all laboratory sites," stated Sam Terese, Chief Operating Officer of Alverno Clinical Laboratories. "We chose Immucor due to the exceptional functionality of the Echo instrument and its fit with LEAN operations as well as Immucor's commitment to improving transfusion medicine."

Immucor's innovative automation strategy provides scalable solutions to meet the needs of all blood banks, regardless of size. Immucor has continually invested in automation since 1998, most recently with the Echo instrument. The Echo, which is designed for smaller volume laboratories, features a broad test menu, instant access and the industry's fastest turnaround times.

About Alverno Clinical Laboratories

Located in Hammond, In., Alverno Clinical Laboratories, LLC is one of the largest regional hospital laboratory integrated delivery systems in the nation. Alverno's operations include a regional core laboratory, 27 hospital laboratories, and a network of patient service centers in both Indiana and Illinois. Alverno is a joint venture of the Sisters of St. Francis Health Services, Inc., Resurrection Health Care and Provena Health. For more information on Alverno, please visit our website at www.alvernoclinicallabs.com.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Immucor Schedules Second Quarter Earnings Release and Conference Call
2. FDA Accepts Immucors Response to Warning Letter
3. Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
4. Immucor CEOs Italian Trial Moves Toward Second Phase
5. Immucor To Acquire BioArray Solutions Ltd.
6. Immucor Responding to FTC Inquiry
7. Immucor Settles SEC Investigation
8. Clinical Data on Peregrines Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting
9. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
10. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
11. Medarex to Host Clinical Program Update Conference Call on Tuesday, June 2, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Ca (PRWEB) , ... August 16, 2017 , ... ... by changing into a different cell type. Many treatments for specific cancers, such ... prominent example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
(Date:8/16/2017)... , Aug. 16, 2017  This year,s edition of the Inc. ... in life sciences workforce solutions, has made the list for the third ... recognizes the nation,s fastest-growing private companies based on a set of quantitative ... which includes the fastest-growing companies in the Bay State ... Inc. 5000 ...
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical ... and biotherapeutics development, announces the launch of the new NHS Agile biosensor ... kinetic binding data for a wide range of molecules, including small and large ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum and The ... through a series of upcoming panels and events. The partnership culminates with the ... Hotel in New York City. , “With our experience in producing the Immuno-Oncology 360° ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):